|
Market Closed -
OTC Markets
09:32:04 2026-05-26 EDT
|
5-day change | 1st Jan Change | ||
| 0.000100 USD | -.--% |
|
-.--% | - |
| 24-08-20 | BIMI Holdings Inc.(OTCPK:BIMI) dropped from NASDAQ Composite Index | CI |
| 24-06-04 | Bimi Holdings Inc. Announces Directorate Changes | CI |
| Market Cap | 25.38M 21.87M 20.51M 18.72M 35.26M 2.43B 35.38M 243M 94.92M 1.22B 95.29M 93.22M 4.06B | P/E 2021 |
-0.39x | P/E 2022 | -0.15x |
|---|---|---|---|---|---|
| Enterprise Value | 33.1M 28.52M 26.74M 24.41M 45.99M 3.16B 46.14M 317M 124M 1.6B 124M 122M 5.3B | EV / Sales 2021 |
0.99x | EV / Sales 2022 | 1.05x |
| Free-Float |
100% | Yield 2021 * |
-
| Yield 2022 | - |
| 1 week | 0 | 0 | |
| 1 month | 0 | 0 | |
| Current year | 0 | 0 | |
| 1 year | 0 | 0 | |
| 3 years | 0 | 4.13 | |
| 5 years | 0 | 133.5 | |
| 10 years | 0 | 1,250 |
| Manager | Title | Age | Since |
|---|---|---|---|
Baiqun Zhong
DFI | Director of Finance/CFO | 63 | 2021-05-20 |
Xiao Ping Wang
COO | Chief Operating Officer | 47 | 2020-02-17 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 6/12/24 | Free | Chairperson | 1,123,500 | 8.0229% | ||
| 2/28/24 | Sell | Chief Executive Officer | 4,000 | 0.0286% | ||
| 2/26/24 | Sell | Chief Executive Officer | 724 | 0.0052% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | -.--% | -100.00% | 1.4K | ||
| +0.32% | +4.02% | +30.11% | +111.86% | 104B | ||
| -0.25% | +2.20% | +57.65% | +161.10% | 54.55B | ||
| +2.29% | -7.59% | -14.10% | +239.24% | 22.12B | ||
| +0.86% | +1.36% | -12.10% | -14.93% | 8.15B | ||
| -0.07% | -1.57% | -37.56% | -28.02% | 7.21B | ||
| -1.05% | +0.93% | +2.68% | +18.68% | 6.36B | ||
| +0.76% | -4.32% | -14.68% | -30.59% | 6.34B | ||
| +0.54% | +2.93% | -1.58% | +21.54% | 5.2B | ||
| +2.78% | +16.03% | +284.53% | +455.00% | 4.29B | ||
| Average | +0.62% | +1.96% | +29.49% | +83.39% | 21.84B | |
| Weighted average by Cap. | +0.41% | +3.12% | +30.84% | +125.45% |
| 2021 | 2022 | |
|---|---|---|
| Net sales | 27.08M 23.33M 21.88M 19.97M 37.62M 2.59B 37.74M 260M 101M 1.31B 102M 99.46M 4.33B | 11.83M 10.19M 9.56M 8.73M 16.44M 1.13B 16.49M 113M 44.24M 571M 44.42M 43.45M 1.89B |
| Net income | -34.99M -30.15M -28.27M -25.8M -48.61M -3.34B -48.76M -335M -131M -1.69B -131M -128M -5.6B | -22.39M -19.3M -18.09M -16.52M -31.11M -2.14B -31.21M -215M -83.75M -1.08B -84.08M -82.25M -3.58B |
| Net Debt | 8.24M 7.1M 6.65M 6.07M 11.44M 787M 11.48M 78.94M 30.8M 397M 30.92M 30.25M 1.32B | 7.72M 6.65M 6.24M 5.69M 10.72M 738M 10.76M 73.99M 28.87M 372M 28.98M 28.35M 1.23B |
Employees
296
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-27 | US$0.000100 | -.--% | 253 |
- Stock Market
- Stocks
- BIMI Stock
Select your edition
All financial news and data tailored to specific country editions
















